576 related articles for article (PubMed ID: 27886889)
41. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
42. [Juvenile myasthenia].
Pogancev MK
Med Pregl; 2011; 64(5-6):295-8. PubMed ID: 21789921
[TBL] [Abstract][Full Text] [Related]
43. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
Bogdan I; Crisanda V
Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
[TBL] [Abstract][Full Text] [Related]
44. History central to diagnosing myasthenia gravis.
Spillane J; Kullmann D
Practitioner; 2010 Sep; 254(1732):15-8, 2. PubMed ID: 21133188
[TBL] [Abstract][Full Text] [Related]
45. [Myasthenia gravis: diagnosis and treatment].
Suárez GA
Rev Neurol; 1999 Jul 16-31; 29(2):162-5. PubMed ID: 10528332
[TBL] [Abstract][Full Text] [Related]
46. Immunosuppressive treatment of ocular myasthenia gravis.
Tackenberg B; Hemmer B; Oertel WH; Sommer N
BioDrugs; 2001; 15(6):369-78. PubMed ID: 11520248
[TBL] [Abstract][Full Text] [Related]
47. [Juvenile myasthenia gravis].
Papazian O; Alfonso I
Medicina (B Aires); 2009; 69(1 Pt 1):71-83. PubMed ID: 19240004
[TBL] [Abstract][Full Text] [Related]
48. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
49. Myasthenia gravis. A well-understood neuromuscular disorder.
Ravits J
Postgrad Med; 1988 Jan; 83(1):219-23. PubMed ID: 3336605
[TBL] [Abstract][Full Text] [Related]
50. Childhood Graves disease masquerading as myasthenia gravis.
Perlman SJ; Zaidman CM
J Child Neurol; 2013 Oct; 28(10):1309-11. PubMed ID: 22952313
[TBL] [Abstract][Full Text] [Related]
51. [Juvenile myasthenia gravis in sub-Saharan Africa: a case study of two consanguine sisters born from consanguinity in Togo].
Maneh N; Apetse K; Diatewa BM; Domingo SA; Agba AI; Ayena KD; Balogou KA; Balo KP
Pan Afr Med J; 2017; 28():63. PubMed ID: 29230265
[TBL] [Abstract][Full Text] [Related]
52. [Myasthenia, from the internist's point of view].
Eymard B
Rev Med Interne; 2014 Jul; 35(7):421-9. PubMed ID: 24112993
[TBL] [Abstract][Full Text] [Related]
53. Combined Guillain-Barré syndrome and myasthenia gravis.
Hsieh MY; Chan OW; Lin JJ; Lin KL; Hsia SH; Wang HS; Chiu CH
Brain Dev; 2013 Oct; 35(9):865-9. PubMed ID: 23177060
[TBL] [Abstract][Full Text] [Related]
54. Acquired myasthenia gravis.
Massey JM
Neurol Clin; 1997 Aug; 15(3):577-95. PubMed ID: 9227954
[TBL] [Abstract][Full Text] [Related]
55. Ophthalmologic clinical features of ocular myasthenia gravis.
Kim DH; Roh HC; Oh SY
Medicine (Baltimore); 2023 Jan; 102(2):e31972. PubMed ID: 36637960
[TBL] [Abstract][Full Text] [Related]
56. Insights in the autoimmunity of myasthenia gravis.
De Baets MH
Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
[TBL] [Abstract][Full Text] [Related]
57. Myasthenia gravis: diagnosis and treatment.
Armstrong SM; Schumann L
J Am Acad Nurse Pract; 2003 Feb; 15(2):72-8. PubMed ID: 12640942
[TBL] [Abstract][Full Text] [Related]
58. [Validation of the ice pack test in ophthalmoparesis due to myasthenia gravis].
Ramirez-Antunez ÁG; García-Ramos G; Estañol-Vidal B; Juárez-Flores A
Rev Neurol; 2013 Nov; 57(9):385-95. PubMed ID: 24150950
[TBL] [Abstract][Full Text] [Related]
59. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
Isshiki Y; Mimura O; Gomi F
Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
[TBL] [Abstract][Full Text] [Related]
60. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
Reddel SW; Morsch M; Phillips WD
Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
